The objective of a phase II cancer clinical trial is to screen a treatment that can produce a similar or better response rate compared to the current treatment results. This screening is usually carried out in two stages as proposed by Simon. For ineffective treatment, the trial should terminate at
β¦ LIBER β¦
Multistage designs for phase II clinical trials: statistical issues in cancer research
β Scribed by Kramar, A; Potvin, D; Hill, C
- Book ID
- 109837311
- Publisher
- Nature Publishing Group
- Year
- 1996
- Tongue
- English
- Weight
- 892 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Optimal three-stage designs for phase II
β
T. Timothy Chen
π
Article
π
1997
π
John Wiley and Sons
π
English
β 136 KB
π 2 views
Practical issues in quality of life asse
β
JΓΌrg Bernhard; Heidi Gusset; Christoph HΓΌrny
π
Article
π
1998
π
John Wiley and Sons
π
English
β 130 KB
π 2 views
Quality of life (QOL) assessment has become an integrated part in some advanced disease trials and to a lesser extent in early disease trials conducted by the Swiss Group for Clinical Cancer Research (SAKK). In general, the concept of QOL endpoints and the additional work of collecting these data is
Phase I/II study of the anti-oestrogen z
β
Stein, RC; Dowsett, M; Cunningham, DC; Davenport, J; Ford, HT; Gazet, J-C; von A
π
Article
π
1990
π
Nature Publishing Group
π
English
β 649 KB
Response of patients in phase II studies
β
Blackledge, G; Lawton, F; Redman, C; Kelly, K
π
Article
π
1989
π
Nature Publishing Group
π
English
β 604 KB
Gemcitabine with or without continuous i
β
Di Costanzo, F; Carlini, P; Doni, L; Massidda, B; Mattioli, R; Iop, A; Barletta,
π
Article
π
2005
π
Nature Publishing Group
π
English
β 97 KB
Phase II clinical trial ofcis-dichlorodi
β
Krsto KolariΔ; Anton Roth
π
Article
π
1983
π
Springer
π
English
β 467 KB